Skip to main content
Clinical Trials/CTRI/2024/09/073308
CTRI/2024/09/073308Not yet recruitingNot Applicable

Role of Patch testing in Lip and Eyelid Dermatitis

Dr Aravind Suprakasan1 site in 1 country20 target enrollmentStarted: September 15, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
Itching or Faint erythema or papules or pustules or vesicles at the site of patch test

Study Overview

Brief Summary

Patients above the age of 18years with symptoms of Lip and eyelid dermatitis will be included in the study. A total of 3 visits to the hospital has to be done for Patch testing. Patch testing will be done using ISS (Indian Standard Series) and Cosmetic Series. On the first visit, a detailed history is taken with regard to the possible allergen exposures, occupation, cosmetic use. A total of 55 patches (20+32) will be kept on the posterior trunk and upper arms (if required) using standard aluminium chambers. Second visit is on the Day 3 (48 hours), when patches will be removed and reading will be done as per the ICDRG guideline. Third visit will be on Day 4 (72 hours) when second reading will be done. In case of excessive itching or discomfort, patch will be removed prior to 48 hours and patient will be withdrawn from the study.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •1.Patients above 18 years of age and less than 60years
  • •Patients attending dermatology OP with lip and eye lid dermatitis.
  • •Patients consenting for patch test.

Exclusion Criteria

  • •Patients on any immunosuppressive treatment (eg : oral corticosteroids, azathioprine, cyclosporine, tofacitinib)
  • •Patients having extensive active dermatitis, exfoliative dermatitis
  • •Pregnant patients
  • •Patients having lesions on the back which will interfere with the application of patch or reading
  • •Patients who are unable to come for 48 hour and 72-hour reading.

Outcomes

Primary Outcomes

Itching or Faint erythema or papules or pustules or vesicles at the site of patch test

Time Frame: first reading at 48 hours after application of patch and second reading at 72 hours

Secondary Outcomes

  • Itching or Faint erythema or papules or pustules or vesicles at the site of patch test(Patch test site positive reaction occurring after 72 hours)

Investigators

Sponsor
Dr Aravind Suprakasan
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Aravind Suprakasan

Kasturba Medical College, Manipal

Study Sites (1)

Loading locations...

Similar Trials